Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-05 | 6 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 306 | $20.50 | $6k |
| 2026-10-05 | 6 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 699 | $20.51 | $14k |
| 2026-10-05 | 6 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 401 | $20.52 | $8k |
| 2026-10-05 | 6 co-filers EVP/Chief Financial Officer |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| 100 |
| $20.52 |
| $2k |
| 2026-10-05 | 6 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 366 | $20.53 | $8k |
| 2026-10-05 | 6 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 200 | $20.54 | $4k |
| 2026-09-11 | Mccuen Michael P EVP/Chief Banking Officer | Tax withholding | 2,312 | $0.00 | $0 |
| 2026-09-04 | 17 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 70 | $21.16 | $1k |
| 2026-09-04 | 17 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 100 | $21.17 | $2k |
| 2026-09-04 | 17 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 100 | $21.19 | $2k |
| 2026-09-04 | 17 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 80 | $21.20 | $2k |
| 2026-09-04 | 17 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 100 | $21.23 | $2k |
| 2026-09-04 | 17 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 100 | $21.23 | $2k |
| 2026-09-04 | 17 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 100 | $21.24 | $2k |
| 2026-09-04 | 17 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 112 | $21.25 | $2k |
| 2026-09-04 | 17 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 100 | $21.25 | $2k |
| 2026-09-04 | 17 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 340 | $21.25 | $7k |
| 2026-09-04 | 17 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 170 | $21.26 | $4k |
| 2026-09-04 | 17 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 100 | $21.27 | $2k |
| 2026-09-04 | 17 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 120 | $21.27 | $3k |
| 2026-09-04 | 17 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 70 | $21.29 | $1k |
| 2026-09-04 | 17 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 160 | $21.30 | $3k |
| 2026-09-04 | 17 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 160 | $21.30 | $3k |
| 2026-09-04 | 17 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 90 | $21.30 | $2k |
| 2026-08-17 | Sohocki Brian J EVP/Chief Credit Officer | Tax withholding | 1,425 | $0.00 | $0 |
| 2026-08-10 | 6 co-filers EVP / Chief Audit Executive | Open-market sale | 3,653 | $21.46 | $78k |
| 2026-08-10 | 6 co-filers EVP / Chief Audit Executive | Open-market sale | 4,808 | $21.46 | $103k |
| 2026-08-10 | 6 co-filers EVP / Chief Audit Executive | Open-market sale | 5,000 | $21.46 | $107k |
| 2026-08-10 | 6 co-filers EVP / Chief Audit Executive | Open-market sale | 4,539 | $21.47 | $97k |
| 2026-08-10 | 6 co-filers EVP / Chief Audit Executive | Open-market sale | 4,000 | $21.48 | $86k |
| 2026-08-10 | 6 co-filers EVP / Chief Audit Executive | Open-market sale | 3,000 | $21.46 | $64k |
| 2026-08-06 | 5 co-filers Group filing | Open-market sale | 3,300 | $21.67 | $72k |
| 2026-08-06 | 5 co-filers Group filing | Open-market sale | 9,746 | $21.70 | $211k |
| 2026-08-06 | 5 co-filers Group filing | Open-market sale | 302 | $21.70 | $7k |
| 2026-08-06 | 5 co-filers Group filing | Open-market sale | 1,342 | $21.73 | $29k |
| 2026-08-06 | 5 co-filers Group filing | Open-market sale | 310 | $21.73 | $7k |
| 2026-08-05 | 12 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 90 | $21.78 | $2k |
| 2026-08-05 | 12 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 200 | $21.79 | $4k |
| 2026-08-05 | 12 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 100 | $21.81 | $2k |
| 2026-08-05 | 12 co-filers EVP/Chief Financial Officer | 10b5-1 plan sale | 90 | $21.82 | $2k |
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
A reverse discounted cash flow is not shown for a bank.
Funded by deposits, so debt-weighted leverage and a WACC are not defined. Capital adequacy (CET1, LCR) is the right question and is not collected yet.
Classified from the filings: SIC code.
Ranked against 16 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JPM | $895.0B | 16.8× | — | 4.9× | 2.8% | — | 31.3% | 15.7% | 13.4% | — | 1,974 |
| BAC | $346.2B | 13.1× | — | 3.1× | 6.8% | — | 27.0% | 10.1% | 4.9% | — | 1,281 |
| C | $203.0B | 17.6× | — | 2.4× | 5.6% | — | 16.8% | 6.7% | 2.5% | — | — |
| COF | $125.7B | 50.8× | — | 2.4× | 36.6% | — | 4.6% | 2.2% | 2.1% | — | 645 |
| USB | $92.6B | 12.9× | — | 3.2× | 4.4% | — | 26.4% | 11.6% | 9.2% | — | 685 |
| PNC | $90.5B | 13.7× | — | 3.9× | 7.2% | — | 30.3% | 11.5% | 5.9% | — | 677 |
| KEY | $22.3B | 13.9× | — | 3.0× | 62.7% | — | 24.3% | 9.0% | 6.0% | — | 248 |
| FHN | $11.0B | 12.4× | — | 3.2× | 7.2% | — | 28.7% | 11.1% | 8.1% | — | — |
| CFR | $9.8B | 15.9× | — | 4.4× | 8.3% | — | 29.0% | 14.2% | 14.2% | — | 149 |
| WBHC | $6.8B | 87.9× | — | 19.1× | 14.2% | — | 21.2% | 13.0% | 12.8% | — | — |
| CBU | $3.3B | 15.7× | — | 4.0× | 9.6% | — | 25.7% | 10.5% | 10.5% | — | 58 |
| PRK | $3.2B | 15.8× | — | 4.8× | 2.9% | — | 27.1% | 13.3% | 12.6% | — | 61 |
| BANC | $2.9B | 15.6× | — | 1.6× | -3.8% | — | 12.6% | 6.5% | 4.1% | — | 48 |
| NBTB | $2.7B | 15.7× | — | 14.8× | 10.4% | — | 92.5% | 8.9% | 8.3% | — | 62 |
| FCF | $2.0B | 14.3× | — | — | — | — | — | 9.8% | 8.9% | — | 58 |
| CASH | $1.6B | 9.6× | — | 1.9× | 5.3% | — | 22.1% | 21.7% | 20.6% | — | 46 |
| HAFC | $960M | 13.0× | 12.1× | 3.5× | 15.3% | — | 28.2% | 9.6% | 9.6% | 0.0× | 38 |
Peers = companies sharing FCF's sector (National Commercial Banks) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 32% of free cash flow, leaving room to grow it and fund buybacks. Last year: $55.5M dividends + $35.8M buybacks = $91.3M returned on $171.5M FCF.
9 consecutive years of dividend increases · 8%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Insufficient data. Current ROIC on all capital: 9%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Interest Expense | $206.6M | $221.6M | $144.3M | $17.7M | $15.3M | $32.9M | $55.4M | $40.0M | $21.8M | $18.6M |
| Pretax Income | $191.4M | $178.2M | $197.6M | $160.2M | $172.8M | $90.2M | $130.8M | $132.8M | $103.7M | $85.2M |
| Income Tax Expense | $39.1M | $35.6M | $40.5M | $32.0M | $34.6M | $16.8M | $25.5M | $25.3M | $48.6M | $25.6M |
| Net Income | $152.3M | $142.6M | $157.1M | $128.2M | $138.3M | $73.4M | $105.3M | $107.5M | $55.2M | $59.6M |
| Per Share | ||||||||||
| EPS (Basic) | $1.48 | $1.40 | $1.55 | $1.37 | $1.45 | $0.75 | $1.07 | $1.09 | $0.58 | $0.67 |
| EPS (Diluted) | $1.47 | $1.39 | $1.54 | $1.37 | $1.44 | $0.75 | $1.07 | $1.08 | $0.58 | $0.67 |
| Weighted Avg Shares (Basic) | 103.2M | 101.9M | 101.6M | 93.6M | 95.6M | 97.5M | 98.3M | 99.0M | 95.2M | 88.9M |
| Weighted Avg Shares (Diluted) | 103.5M | 102.2M | 101.8M | 93.9M | 95.8M | 97.8M | 98.6M | 99.2M | 95.3M | 88.9M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-10-30
Where each multiple sits in its own 14-yr range · 93th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 10% against ROIC 9% — 1% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on FCF: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Leverage ratios is not shown for a bank.
Funded by deposits, so debt-weighted leverage and a WACC are not defined. Capital adequacy (CET1, LCR) is the right question and is not collected yet.
Classified from the filings: SIC code.
How much the company owes, how it's trended, and how comfortably it's serviced.
$0 of principal comes due within a year. Scheduled principal only (excludes interest & revolver draws). As of 2013-12-31 (10-K). The cash figure is from 2025-12-31, so the two are not the same balance-sheet date — the schedule has not been refiled since.
Interest expense isn't separately reported — often netted into “other income (expense), net.” Effective rate ~139.6% on $148.0M of debt.
Cash vs short-term debt unavailable.
Mostly short-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
No positive operating income in the last three years, so there is no return on capital to compare against its cost.
Return on equity (10%) and return on invested capital (9%) are within a couple of points in FY2025, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: positive EBIT.
Converts 0.99x of reported profit into free cash flow over 5 years, with accruals negative.
Shares outstanding are up 5% since FY2019 — per-share cash flow has grown more slowly than the totals above, and the gap is the owners'.
Missing from our data, so excluded from this answer: share_based_compensation.
Leverage is not measurable this way for a bank.
This schedule comes from a filing dated 2013-12-31, 4687 days old. Maturities are shown relative to that date, not to today.
Ladder as of 2013-12-31 (10-K); cash from the 2025-12-31 balance sheet; FCF from FY2025. No cash figure on the matching balance sheet, so no coverage line is drawn.
Funded by deposits, so debt-weighted leverage and a WACC are not defined. Capital adequacy (CET1, LCR) is the right question and is not collected yet.
Missing from our data, so excluded from this answer: capital adequacy metrics for this archetype.
At $21.00, free cash flow must compound 4.51%/yr for 10 years. It has done 11.29%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | 8.7% | 4.5% |
| FY2021 | 57.4% | 4.5% |
| FY2022 | −9.2% | 4.5% |
| FY2023 | −8.2% | 4.5% |
| FY2024 | −11.5% | 4.5% |
| FY2025 | 50.5% | 4.5% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM.
The cost of capital could not be computed for this company, so the requirement is solved at the published 10% default — a different rate would move it materially.
| Step | Amount | Running total |
|---|---|---|
| Net income | $152M | $152M |
| Share-based comp | not reported | not reported |
| Other non-cash & working capital | $35M | $188M |
| Operating cash flow | $188M | $188M |
| Capex | −$16M | $171M |
| Free cash flow | $171M | $171M |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -0.0 percent |
| FY2020 | -0.4 percent |
| FY2021 | -0.3 percent |
| FY2022 | -0.2 percent |
| FY2023 | 0.1 percent |
| FY2024 | 0.1 percent |
| FY2025 | -0.3 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.